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E sophageal motility disorders such as achalasia are characterized by the absence of esophageal peri-
stalsis and abnormal relaxation of the lower esophageal 
sphincter [1 , 2].  Most patients present with symptoms 
such as dysphagia,  chest pain,  vomiting,  and aspira-
tion.  The standard treatment for esophageal motility 
disorders includes endoscopic balloon dilatation and the 
Heller-Dor procedure.  Peroral endoscopic myotomy 
(POEM) has been reported to have high efficacy with 
low invasiveness [3].  The popularity of POEM as a 
treatment for esophageal motility disorders has 
increased,  and reports of successful cases are common.  
However,  POEM is a novel procedure and is considered 
difficult and risky for inexperienced institutions or phy-
sicians to introduce without instruction from experts.  
POEM was recently introduced to Okayama University 
Hospital under the supervision of a physician from a 
high-volume center.  Here,  we now report the safety and 
efficacy of POEM during the introduction period in our 
institution.
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Peroral endoscopic myotomy (POEM) for treatment of esophageal motility disorders has recently been reported 
to be highly effective and less invasive than other treatment.  POEM was recently introduced in Okayama 
University Hospital under the supervision of a physician from a high-volume center.  To verify the safety and 
efficacy of POEM during its introduction in our institution.  We examined 10 cases in whom POEM was per-
formed between January 2016 and April 2017.  The patients included 7 men and 3 women,  with a median age 
(range) of 49 years (17-74) and median symptom duration of 6 years (1-21).  Seven patients had a straight 
esophagus,  and the remaining 3 had a sigmoid esophagus.  According to the Chicago classification,  6 patients 
were diagnosed with type I achalasia,  2 with type II achalasia,  and 2 with distal esophagus spasm.  Treatment 
outcomes and adverse events were evaluated.  Treatment success was defined as a > 3 decrease in Eckardt score 
or a score of < 3 at the time of discharge.  The treatment success rate was 90%,  with the average Eckardt score 
decreasing significantly,  from 4.7 to 0.9 (p< 0.05).  No mucosal perforation,  severe infection,  mediastinitis,  
severe bleeding,  or gastroesophageal reflux occurred intraoperatively or postoperatively.  POEM was intro-
duced to Okayama University Hospital,  and the first 10 cases were accomplished safely and effectively under the 
supervision of an expert physician from a high-volume center.
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Materials and Methods
This study examined 10 cases in whom POEM was 
performed between January 2016 and April 2017.  All 
procedures were performed by Y.S.,  whose past practice 
included 20 cases of POEM in 3 years at Showa Uni-
versity Northern Yokohama Hospital,  along with 
Professor Inoue as one of the developers of the proce-
dure.  Patient characteristics,  treatment outcomes,  and 
adverse events were evaluated.  In all cases,  endoscopy,  
high-resolution manometry (HRM),  and radiographic 
examinations were performed before POEM.  A blood 
biochemical examination was performed in each patient 
to evaluate any association of secondary esophageal 
motility disorders and achalasia with systemic diseases,  
and pathological examination of esophageal biopsies 
was performed for the diagnosis of eosinophilic esoph-
agus and other disorders.  HRM was used to distinguish 
between achalasia and distal esophagus spasm (DES),  
based on the Chicago classification [4].  Achalasia was 
diagnosed on the parameter of integrated relaxation 
pressure (IRP) greater than 15 mmHg,  and 100% failed 
peristalsis or spasm.  Type I achalasia shows no con-
tractility and Type II achalasia shows more than 20% 
panesophageal pressurization,  and Type III was achala-
sia shows more than 20 spasms.  DES was diagnosed by 
the parameter of IRP,  short distal latency,  distal con-
tractile integral and 100% failed peristalsis [5].
Patient characteristics. The patients included 7 
men and 3 women,  with a median age (range) of 49 
years (17-74 years) and symptom duration of 6 years 
(1-21 years).  The mean (range) Eckardt score before 
POEM was 4.7 (2-8) (Table 1).  Seven patients had a 
straight esophagus,  and 3 had sigmoid esophagus.  
According to the Chicago classification,  measurements 
of esophageal pressure by HRM were used in diagnos-
ing type I achalasia in 6 cases,  type II in 2 cases,  and 
DES in 2 cases.  Two patients had a history of endo-
scopic balloon dilation (Table 2).
All patients were kept on a liquid diet for 1 day prior 
to the procedure.  Intravenous antibiotics were started 
the day of the procedure and continued for 2 days.  
POEM was performed under general anesthesia,  with 
the patient in a supine position.  An upper gastrointes-
tinal endoscope equipped with a water jet (Olympus 
GIF Q260J; Olympus Corp.,  Tokyo,  Japan) was used 
for the procedure,  and a transparent cap with a tapered 
end (DH-28GR; Fujifilm,  Tokyo,  Japan) was used in all 
cases.
Myotomy was performed on the posterior wall (5 
o’clock position) of the esophagus.  as follows.  In step 1,  
a submucosal injection was performed (Fig. 1A).  In step 
2,  an incision of a few millimeters was made to allow 
entry into the submucosal tunnel.  In step 3,  a submu-
cosal tunnel was created by dissecting the fibers with a 
triangular tip knife (Triangle Tip Knife,  KD-640 L;  
Olympus Corp. ) and using spray coagulation (Fig. 1B).  
In step 4,  the tunnel was extended across the gastro-
esophageal junction for at least 2 cm.  In step 5,  in the 
circular rather than longitudinal muscle,  myotomy was 
performed at the proximal esophagus and gastroesoph-
ageal junction (Fig. 1C).  In step 6,  the end-point was 
determined using another ultrathin scope.  With an 
additional ultrathin endoscope in place in the stomach,  
the main endoscope was placed closer to the anal side in 
the submucosal tunnel.  Then,  the light of the main 
scope was observed with an additional ultrathin scope 
to confirm that the muscle layer incision was sufficient 
[6] (Fig. 1D).  Finally,  in step 7,  the mucosal incision 
was closed using endoclips (EZ Clip,  HX-610-090 L;  
Olympus Corp. ) from the distal to the proximal end 
(Fig. 1E).  Treatment success was defined as a > 3 
decrease in Eckardt score (Table 1) or a score of < 3 at 
the time of discharge after POEM.  The study was 
approved by the local ethics review committee (approval 
No. 2018) and registered in the University Hospital 
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Table 1　 Eckardt score
Symptom
Score
0 1 2 3
Dysphagia None Occasional Daily With every meal
Regurgitation None Occasional Daily With every meal
Chest pain None Occasional Daily Several times a day
Weight loss (kg) 0 ＜5 5～10 ＞10
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Table 2　 Charactaristics of patietns performed POEM at Okayama University Hospital from January 2016 to April 2017.
No. Age Gender Past history Past treatment
Duration of
symptoms (year)
Chicago
classiﬁcation
X-ray
examination
1 39 M none none  4 Ⅰ Straight(Spindle)
2 22 M lung abscess none  1 Ⅰ Straight(Flask)
3 46 M appendicitis none  5 Ⅰ Sigmoid
4 59 F breast cancer none  1 Ⅱ Straight(Spindle)
5 74 M
angina pectoris,  diabetis,
hypertension hyperurisemia,
appendicitis
none  6 DES Straight(Spindle)
6 50 F appendicitis peumotic dilation 21 Ⅰ Sigmoid
7 38 M depression none  7 Ⅰ Straight (Spindle)
8 67 M ureter stone none  4 DES Straight (Spindle)
9 74 M none none  8 Ⅱ Straight (Spindle)
10 17 F none peumotic dilation  4 Ⅰ Sigmoid
DES,  distal esophagus spasm.
A B C
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Fig. 1　 Endoscopic images of the POEM 
procedure.  POEM was performed using the 
following steps.  Submucosal injection was 
performed (A),  and a submucosal tunnel 
was created by dissecting the ﬁbers (B).  
The tunnel was extended across the gas-
troesophageal junction for at least 2 cm.  
Myotomy of Circular rather than longitudi-
nal muscle was performed at the proximal 
esophagus and gastroesophageal junction 
(C).  The ultrathin endoscope in the stom-
ach conﬁrmed light from the main endo-
scope in the submucosal tunnel (yellow 
arrow) (D).  The mucosal incision was 
closed from the distal to the proximal end 
of the incision (E).
Medical Network Clinical Trials Registry (reference No. 
UMIN 000016126).
Results
The mean Eckardt score (range) was 4.7 (2-8) before 
POEM and 0.9 (0-4; p < 0.05) after POEM.  The success 
rate was 90% at the time of discharge.  The median pro-
cedure time was 82 min (45-110 min).  The median 
total myotomy length was 11.1 cm (4-17 cm),  with 
median esophageal and gastric myotomy lengths of 
9.6 cm (3-16 cm) and 1.5 cm (0-2 cm),  respectively.  
Postoperative hospital stay was 4.3 days (4-6 day).  
Blood transfusions were not necessary in all cases.
In the present study,  there were no adverse events,  
including mucosal perforation,  mediastinitis,  severe 
pne-umomediastinum,  severe pneumothorax,  postop-
erative bleeding,  or gastroesophageal reflux disease 
(GERD),  during or after POEM (Table 3).
Discussion
This study examined the results of the first 10 cases 
of POEM during the introduction period in our institu-
tion.  This was the first use of POEM in the Chugoku 
and Shikoku regions in Japan.  Every case was per-
formed in an operating room and under anesthesia.  As 
this was the first use of this operative technique in our 
hospital,  we consulted Professor Inoue in advance 
regarding the devices and systems needed.  We formed 
a POEM team (Y.S.,  K.Y.,  and R.K.),  and the initial 
surgeon was Y.S. in all 10 cases.  Professor Inoue pro-
vided verbal advice while standing behind the initial 
surgeon.  We found that the POEM procedure,  espe-
cially the decision of the position for submucosal entry,  
differs in each case,  because abnormal,  significantly 
strong,  or corkscrew-like peristalsis is different in each 
patient.  The decision of the position of the submucosal 
entry and the extent of myotomy can be informed by 
pre-operative endoscopic and radiographic findings,  
but is ultimately decided during the procedure.  It is 
difficult for a beginner to determine whether abnormal 
peristalsis is present or not,  and even more difficult to 
determine the optimal site of submucosal entry.  
Therefore,  guidance by Professor Inoue during POEM 
was essential.  Having performed a total of 30 cases,  
including 10 at our hospital,  the operator (Y.S.) is now 
able to proceed without guidance.
The success rate of POEM in the present study was 
90% at the time of discharge,  comparable to that found 
by the International Per Oral Endoscopic Myotomy 
Survey (2013),  which examined the success rate and 
safety of POEM [7].   Costamagna et al.  reported that 
POEM was technically feasible in 10 of 11 (91%) 
patients,  and clinical success,  defined as Eckardt ≤ 3 at 
1 month,  was obtained in all 10 treated patients [8].  
Hungness et al.  reported similar treatment success in 16 
of 18 patients (89%) who underwent POEM,  with 
Eckardt scores ≤ 3 and significant reductions in lower 
esophageal sphincter pressure and barium column 
height [9].  In the present study,  only one case,  No. 5,  
had not obtained sufficient therapeutic effect at dis-
charge to be considered a success.  POEM was per-
formed while the patient remained on aspirin.  One day 
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Table 3　 Result of performed POEM at Okayama University Hospital from January 2016 to April 2017.
No. Age Gender
Eckardt score Operating
time
(minutes)
Postoperative
hospital stay
(days)
Length of 
submucosal
tunnel (cm)
Total
myotomy
length (cm)
Before
POEM
After
POEM
1 39 M 5 0 95 4 13 12
2 22 M 3 0 80 4 6 4
3 46 M 2 2 110 6 10 8
4 59 F 8 1 95 4 16 15
5 74 M 5 4 90 5 20 16
6 50 F 6 1 90 4 9 8
7 38 M 7 1 60 4 11 9
8 67 M 2 0 70 4 15 15
9 74 M 6 0 85 4 18 17
10 17 F 3 0 45 4 9 7
after POEM,  a transient submucosal hematoma devel-
oped including transient dysphagia.  This patient’s 
Eckardt score was still high,  at 4,  at the time of dis-
charge.  After 6 months,  his Eckardt score was 0 and he 
has required no further treatment.  In other words,  
after 6 months,  the success rate of 10 patients enrolled 
at our hospital was 100%.
Although POEM was originally developed as a treat-
ment for achalasia,  recently,  there have been several 
reports on POEM for DES; they stated that POEM has 
a high therapeutic effect for DES as well [10 , 11].  In the 
present study,  although only a few cases of achalasia 
and DES (No. 5 and No. 8) were examined,  we obtained 
100% therapeutic effect equally for achalasia and DES.  
Therefore,  we consider that POEM is equally effective 
for achalasia and DES.
Regarding adverse events,  in general,  POEM is only 
performed on the circular muscle and not the longitu-
dinal muscle.  However,  the external longitudinal mus-
cle is very thin,  and splits naturally with pressure from 
the endoscopic carbon dioxide supply.  Therefore,  the 
mediastinum is usually seen through the muscle fibers 
[12].  In almost all POEM cases,  the tissue of the medi-
astinum was observed from the submucosal tunnel with 
an endoscope.  However,  this means penetration from 
one germfree space to another germfree space (submu-
cosal and mediastinum).  Therefore,  it is completely 
different from the concept of gastrointestinal perfora-
tion as an adverse event,  such as that occurring during 
ESD,  when an external space (the gastrointestinal 
lumen) makes contact with a germ-free space.  Unless 
the mucosal layer is damaged,  there is no risk of caus-
ing mediastinitis at all in POEM,  as long as the entry of 
the submucosal tunnel is well clipped.  Therefore,  per-
foration during POEM as an adverse event means 
mucosal perforation.  A previous study reported a rate 
of perforation and mucosal damage of 0-7% [13].  Even 
if perforation of the mucosal layer is recognized during 
the procedure,  clip closure of the perforated lesion of 
the mucosal layer will be effective in many cases.
The incidence of a gas-related adverse event,  minor 
pneumomediastinum,  immediately after POEM,  was 
100%.  However,  this was without clinical significance 
or need for special treatment,  and should not be con-
sidered an adverse event.  This phenomenon should be 
considered similar to the pneumomediastinum seen 
after thoracoscopic surgery.  Therefore,  in POEM,  the 
only gas-related adverse events are severe pneumome-
diastinum or severe pneumothorax,  with need for 
additional treatment,  such as thoracic drainage.  Major 
bleeding occurs infrequently during the procedure,  
probably because few vessels are encountered in the 
submucosal tunnel.  Almost all bleeding can be treated 
by endoscopic coagulation.  GERD occurs frequently 
and is a logical consequence of the treatment,  although 
it can be easily treated with a proton-pump inhibitor 
and is not considered an adverse event.  Delayed bleed-
ing was previously reported in 1.1% of POEM patients 
[14].  In the present study,  the intraoperative and post-
operative adverse events were consistent with those in 
other reports.  There were no cases of perforation,  
mucosal damage,  severe bleeding,  severe infection,  or 
mediastinitis.  Since we introduced POEM 17 months 
ago all patients remain alive and show no recurrence of 
symptoms,  including GERD or chest pain.
The reasons for the positive results in the present 
study were as follows.  First,  the initial operator had 
trained at Showa University Northern Yokohama 
Hospital.  POEM is unlike other endoscopic procedures 
with myotomy performed using endoscopy alone.  It is 
necessary for the initial operator to have sufficient 
training at an institution performing POEM.  Second,  
Professor Inoue was consulted and provided advice for 
each of the 10 initial POEM cases performed in our 
hospital.  We were able to adhere to the POEM protocol 
because real-time advice was provided during surgery.  
It was also necessary to consult Dr. Inoue to determine 
whether the patients were candidates for POEM.  Third,  
and most important,  it is essential to thoroughly 
explain the POEM procedure to doctors in the depart-
ments of gastrointestinal surgery and anesthesia.  We 
believe that an endoscopist should not independently 
attempt POEM.  A safe technique and successful proce-
dure requires close cooperation with other depart-
ments.
In conclusion,  POEM was introduced at Okayama 
University Hospital and the first 10 cases were per-
formed safely and effectively under the supervision of an 
expert physician from a high-volume center.
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